Hemony Pharmaceutical

Hemony Pharmaceutical is a prominent Chinese pharmaceutical company headquartered in Chongqing, specializing in the research, development, manufacturing, and commercialization of high-quality medicines. Established in 2010, the company focuses on key therapeutic areas such as gastroenterology, the central nervous system (CNS), pediatrics, oncology, and nephrology. Hemony employs a strategic business model that combines proprietary drug development with extensive in-licensing and distribution partnerships with global pharmaceutical leaders like Sanofi and AstraZeneca. The company operates multiple GMP-certified manufacturing facilities and maintains a robust commercial network that reaches thousands of hospitals and pharmacies across China. Backed by major investors including Goldman Sachs, Hemony continues to expand its portfolio of oral solids and liquid formulations to address significant unmet medical needs in the Chinese market.